To study the usefulness of Fosfomycin in the treatment of drug resistant urinary tract infections (UTI) among diabetic patients.
Not Applicable
- Conditions
- Health Condition 1: N390- Urinary tract infection, site notspecified
- Registration Number
- CTRI/2023/04/051236
- Lead Sponsor
- Dr Sreemedha Choudhury
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
UTI Patients who are known cases of Diabetes Mellitus, having UTI symptoms like frequency, urgency, burning micturition etc.
Exclusion Criteria
Patient refusing to participate in the study
Psychotic Patients
Patients with asymptomatic bacteriuria
Pregnant females
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Effectiveness of Fosfomycin drug in Carbapenem-susceptible and Carbapenem-resistant Multidrug Resistant Enterobacterales (MDRE) UTI in diabetic patientsTimepoint: Baseline(1st visit) and 2 weeks
- Secondary Outcome Measures
Name Time Method Study the susceptibility profile of MDRE in diabetic UTI patientsTimepoint: Baseline and at 2 weeks;To identify the risk factors associated with MDRETimepoint: Baseline;Try to assess the prevalence of MDRE UTI in diabetic patients in a tertiary healthcare centre of AligarhTimepoint: Baseline